Indeed, the trans-differentiation from LAC to SqCC has been described both in humans and in mouse models, often when tumor cells are characterized by inactivation of the tumor suppressor gene LKB1/STK11, which occurs in up to 20% of LACs [3,7,10,238,239]. The gene discussed is STK11; the disease is neoplasm.